Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,368.85
(
-1.67%
)
US TECH 100
22,405.20
(
-2.38%
)
Dow Jones
45,166.64
(
-1.73%
)
Brent Oil
106.89
(
0.00%
)
Bitcoin
66,388.00
(
0.10%
)
News Focus
News Focus

Replies to post #1937 on Enanta Pharmaceuticals Inc (ENTA)

Replies to #1937 on Enanta Pharmaceuticals Inc (ENTA)
icon url

DewDiligence

02/10/21 2:45 PM

#1938 RE: DewDiligence #1937

ENTA’s_enterprise value_at_the_current_share_ price ($54.78) is ~$870M, based on 23.9M fully-diluted shares (#msg-161707883) and pro forma cash of $441.4M (#msg-161707561).
icon url

DewDiligence

05/19/21 3:11 PM

#1962 RE: DewDiligence #1937

ENTA’s fully-diluted* share count @3/31/21=24.1M—an increase of 0.2M since 12/31/20 (#msg-161707883).

The 24.1M figure above consists of: 20.2M basic shares on the 3/31/21 balance sheet (https://www.sec.gov/ix?doc=/Archives/edgar/data/1177648/000156459021026025/enta-10q_20210331.htm#CONSOLIDATED_BALANCE_SHEETS ); and 3.9M options outstanding at 3/31/21 (whether or not exercisable) (ibid, page 13).

*Non-treasury method.